Why Are DNB Shares Falling Today?

Dun & Bradstreet stock is trading -29.16% below its average target price of $14.92 after dropping -2.4% during today's afternoon session. Analysts are giving the mid-cap Diversified Financial company an average rating of buy and target prices ranging from $11.0 to $18.0 per share.

Dun & Bradstreet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4.7%. The stock's short ratio is 5.36. Since 10.87% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 87.6%. In conclusion, we believe there is positive market sentiment regarding Dun & Bradstreet.

Institutions Invested in Dun & Bradstreet

Date Reported Holder Percentage Shares Value
2023-03-31 Cannae Holdings, Inc. 18% 79,048,691 $835,544,639
2023-03-31 Thomas H Lee Partners LP 11% 49,579,771 $524,058,164
2022-12-31 Capital International Investors 6% 25,513,000 $269,672,402
2022-12-31 Vanguard Group, Inc. (The) 5% 23,700,703 $250,516,423
2022-12-31 StepStone Group LP 5% 22,042,226 $232,986,322
2023-03-31 Massachusetts Financial Services Co. 4% 18,469,175 $195,219,174
2022-12-31 Blackrock Inc. 4% 15,658,399 $165,509,272
2023-03-31 Allspring Global Investments Holdings, LLC 3% 14,113,815 $149,183,020
2023-03-31 Mawer Investment Management Ltd. 3% 13,623,538 $144,000,792
2022-12-31 Millennium Management Llc 2% 7,048,517 $74,502,822
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.